Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Gail P Risbridger

21PUBLICATIONS
209CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Gene mapping
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

Sort by Publication Date:
|Oct 29, 2025
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models.

Xin Du, Pei K Goh, Chenkai Ma

|Apr 25, 2025
p-AKT Protein Expression Predicts Response to AKT Inhibitor Combined with Docetaxel Therapy in Adenocarcinoma and Neuroendocrine Prostate Cancer.

Hipacia Werneck Gomes, Natalie L Lister, Shivakumar Keerthikumar

|Oct 25, 2024
Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson

|Aug 08, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson

|Jun 08, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.

Zifeng Wang, Scott L Townley, Songqi Zhang

|Mar 07, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer research.

W Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna

Pageof 4

Frequent Collaborators

11 joint publications

Renea A Taylor

6 joint publications

Mitchell G Lawrence

5 joint publications

Wayne Tilly

4 joint publications

Luke A Selth

3 joint publications

Arun Azad

3 joint publications

Eva Corey

3 joint publications

Declan G Murphy

3 joint publications

Mark Frydenberg

3 joint publications

Laura H Porter

3 joint publications

Alisha J Chou

Frequent Collaborators

11 joint publications

Renea A Taylor

6 joint publications

Mitchell G Lawrence

5 joint publications

Wayne Tilly

4 joint publications

Luke A Selth

Top Related Videos

Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells
06:22

Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells

Published on : Feb 02, 2024

4.8K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.2K
A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TE<sup>deff</sup>) in Cancers
10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TE<sup>deff</sup>) in Cancers

Published on : Sep 26, 2019

5.6K
See more related videos

Top Related Videos

Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells
06:22

Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells

Published on : Feb 02, 2024

4.8K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.2K
A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TE<sup>deff</sup>) in Cancers
10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TE<sup>deff</sup>) in Cancers

Published on : Sep 26, 2019

5.6K
See more related videos